Holen Sie sich die Stockscreener-App
2.1203
26.65%
0.4503
Schlusskurs vom Vortag:
$1.67
Offen:
$1.975
24-Stunden-Volumen:
42.27M
Relative Volume:
8.01
Marktkapitalisierung:
$47.68M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.3197
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
+97.66%
1M Leistung:
+60.23%
6M Leistung:
+131.27%
1J Leistung:
-23.37%
1-Tages-Spanne:
$1.93
$2.44
1-Wochen-Bereich:
$0.98
$2.44
52-Wochen-Spanne:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.1202 | 37.55M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.32 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.40 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
416.85 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
894.11 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.54 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
Alle ansehen
iBio Inc Aktie (IBIO) Neueste Nachrichten
3 Penny Stocks to Watch Now, 12/9/25 - TipRanks
Analyst Upgrade: Will iBio Inc stock outperform international peersQuarterly Trade Review & Accurate Intraday Trading Signals - BỘ NỘI VỤ
iBio Rockets: Is It a Mirage or Real Boost? - StocksToTrade
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
iBio’s New Approach: Game Changer or Just Artifice? - timothysykes.com
iBio (IBIO) Price Target Increased by 14.56% to 4.81 - Nasdaq
Can iBio Inc. stock sustain free cash flow growthJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Is iBio Inc. (0JV0) stock a fit for income portfoliosQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
IBIO: Long-acting antibody pipeline targets obesity gaps, with IND filings and first-in-human trials ahead - TradingView
Will iBio Inc. (0JV0) stock test record highs in 2025Weekly Risk Summary & Proven Capital Preservation Tips - Newser
IBIO: AI-driven antibody programs target obesity gaps with IND filings and first-in-human trials ahead - TradingView
Can iBio Inc. stock deliver sustainable ROE2025 Volume Leaders & High Conviction Investment Ideas - Newser
How iBio Inc. stock reacts to oil pricesMarket Movement Recap & High Accuracy Swing Entry Alerts - Newser
Why iBio Inc. (0JV0) stock could rally strongly2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Why iBio Inc. (0JV0) stock trades below fair valueLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How iBio Inc. (0JV0) stock responds to job market shiftsEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Why analysts raise outlook for iBio Inc. (0JV0) stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Aug Patterns: Should I hold or sell iBio Inc stock in 2025New Guidance & Proven Capital Preservation Tips - BỘ NỘI VỤ
iBio (IBIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why retail traders accumulate iBio Inc. (0JV0) stockJuly 2025 Breakouts & Verified Entry Point Signals - Newser
How robust is iBio Inc. (0JV0) stock financial positionJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Activity Recap: How institutional buying supports iBio Inc. stockJuly 2025 Final Week & AI Driven Stock Reports - moha.gov.vn
iBio, Inc. Reports Q3 2025 Financial Results - MSN
What technical charts say about iBio Inc. stockQuarterly Earnings Report & Long-Term Safe Investment Plans - BỘ NỘI VỤ
How institutional buying supports iBio Inc. stockPortfolio Gains Summary & Stepwise Trade Execution Plans - BỘ NỘI VỤ
iBio to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
[Form 4] iBio, Inc. Insider Trading Activity - Stock Titan
IBIO Form 4 shows director awarded 13,500 options at $1 - Stock Titan
IBIO Form 4: Director awarded 13,500 stock options at $1 - Stock Titan
iBio Form 4 shows director award of 13,500 stock options - Stock Titan
iBio shareholders elect directors and approve annual meeting proposals By Investing.com - Investing.com Canada
iBio Confirms Directors and Auditor at Annual Meeting - TipRanks
iBio shareholders elect directors and approve annual meeting proposals - Investing.com
[8-K] iBio, Inc. Reports Material Event | IBIO SEC FilingForm 8-K - Stock Titan
Can trapped investors hope for a rebound in iBio Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
iBio, Inc. (IBIO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Is iBio Inc. stock safe for conservative investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
Why hedge funds are buying iBio Inc. stockJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Will iBio Inc. stock deliver better than expected guidanceMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Is iBio Inc. (0JV0) stock supported by free cash flowJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock is rated strong buyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Why iBio Inc. stock appeals to dividend seekersJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.25%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):